Enable job alerts via email!
Boost your interview chances
Create a job specific, tailored resume for higher success rate.
A leading company in AI-driven drug discovery seeks a skilled professional to bridge AI research and experimental teams. The role involves leveraging AI techniques for drug discovery, collaborating with various stakeholders, and requires strong data science and software engineering skills.
About The Team
We’re a tight-knit team of proven drug hunters, deep learning researchers, and software engineers united by a common mission — drive AI innovation in biochemistry, discovering and developing groundbreaking therapies for patients suffering from severe disorders.
Genesis AI team is focused on developing foundation models for drug discovery by conducting fundamental research at the intersection of machine learning, physics, and computational chemistry, as well as engineering robust software systems that enable running large-scale simulations and training generative and predictive AI models designed to learn from all kinds of molecular data, leveraging our cluster with thousands of GPUs and CPUs.
About The Role
This unique role serves as a critical bridge between our AI research and experimental drug discovery teams. You will collaborate closely with both groups, leveraging cutting-edge AI techniques to evaluate, analyze, and deploy models to maximize the impact of our industry-leading AI platform on drug discovery programs.
The ideal candidate will be comfortable in experimental and engineering contexts and skilled at communicating with stakeholders from both domains. Their day-to-day responsibilities will require basic familiarity with experimental techniques, excellent data science skills, and demonstrated ability in applied ML.
Positions are available at various levels of seniority: Senior, Staff, and Principal.
You will
You are
Nice to have's
Compensation, Benefits, And Perks
About Genesis Therapeutics
Genesis Therapeutics is unifying AI and biotech to discover novel and breakthrough treatments for patients with severe and devastating conditions. Founded on groundbreaking molecular ML research, Genesis has established itself as an industry leader in AI for small molecule drug discovery. Our team has created the industry's most advanced molecular AI platform, GEMS (Genesis Exploration of Molecular Space), to accelerate and optimize small molecule drug discovery and enable the discovery of novel first-in-class and best-in-class drugs for challenging targets.
We have built an internal pipeline with multiple programs against high-value, data-poor, and undruggable targets, where GEMS provides a distinct advantage. Genesis has signed AI-focused platform collaborations with major pharmaceutical companies, including Incyte Corporation (Feb 2025) and Gilead Sciences (Sept 2024).
We raised a $200M Series B in August 2023 and over $300M from top investors, including Andreessen Horowitz, Rock Springs Capital, T. Rowe Price, Fidelity, Radical Ventures, NVentures, BlackRock, and Menlo Ventures.
Genesis is headquartered in Burlingame, CA, with a fully integrated laboratory in San Diego. We are committed to an inclusive workplace and are an Equal Opportunity Employer.